Positive initial data reported from Phase 1a Single Ascending Dosestudy in nAMD in December 2025; preliminary data from ongoing Phase 1b/2 study ...
The introduction of the first disease-modifying therapies fundamentally transformed the management of geographic atrophy and brought new changes and challenges in clinical practice, workflow and ...
Macular degeneration usually refers to the age-related degenerative changes in the retina that can result in loss of central vision. It is caused by abnormal blood vessel growth (a condition referred ...